
Roopa Industries Downgraded to Sell Amid Mixed Financials and Weak Technicals
2026-06-09 08:44:44Roopa Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 8 June 2026. This change reflects a complex interplay of deteriorating technical indicators, mixed financial trends, valuation considerations, and quality assessments, signalling caution for investors despite recent positive quarterly results.
Read full news articleAre Roopa Industries Ltd latest results good or bad?
2026-06-02 19:30:21Roopa Industries Ltd's latest financial results for Q4 FY26 present a complex picture. The company reported a net loss of ₹1.43 crores, a significant shift from a profit of ₹0.77 crores in the previous quarter (Q3 FY26). This marks a notable decline in net profitability, raising concerns about the sustainability of its growth trajectory. On the revenue front, Roopa Industries generated ₹30.14 crores in Q4 FY26, reflecting a sequential decline of 10.14% from ₹33.54 crores in Q3 FY26, although it achieved a modest year-on-year growth of 1.04% compared to ₹29.83 crores in Q4 FY25. This sequential revenue drop may indicate normal quarterly volatility rather than a fundamental weakening in demand. Despite the challenges at the net profit level, the company demonstrated operational improvements, achieving an operating margin of 10.19%, the highest in eight quarters. This represents a substantial enhancement fro...
Read full news article
Roopa Industries Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-06-02 08:03:31Roopa Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating. This change comes despite mixed returns relative to the broader market and peers, signalling a potential opportunity for investors seeking value in a challenging industry environment.
Read full news article
Roopa Industries Q4 FY26: Loss-Making Quarter Raises Red Flags Despite Revenue Gains
2026-06-01 15:43:01Roopa Industries Ltd., a micro-cap pharmaceutical bulk drug manufacturer with a market capitalisation of ₹41.00 crores, reported a concerning loss of ₹1.43 crores in Q4 FY26, marking a sharp reversal from the ₹0.77 crores profit recorded in the previous quarter. The Adoni-based company, which trades at ₹52.90 on the exchanges, saw its stock gain 2.66% in the trading session following the results announcement, though the counter remains down 21.07% over the past year.
Read full news article
Roopa Industries Ltd Reports Strong Quarterly Profit Growth Amid Revenue Decline
2026-06-01 12:01:03Roopa Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a marked improvement in its financial trend for the quarter ended March 2026. Despite a decline in net sales, the company posted its highest quarterly operating profit and net profit after tax in recent history, signalling a significant turnaround in profitability metrics and operational efficiency.
Read full news article
Roopa Industries Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges
2026-05-22 08:16:40Roopa Industries Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 21 May 2026, driven primarily by a shift in technical indicators despite ongoing fundamental challenges. The pharmaceutical micro-cap’s technical trend has improved to mildly bullish, prompting a reassessment of its outlook, although valuation and financial trends remain subdued.
Read full news articleWhen is the next results date for Roopa Industries Ltd?
2026-05-21 23:18:38The next results date for Roopa Industries Ltd is scheduled for 30 May 2026....
Read full news article
Roopa Industries Ltd is Rated Strong Sell
2026-05-12 10:11:08Roopa Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Roopa Industries Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses
2026-04-28 08:30:06Roopa Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 27 April 2026. This revision reflects a combination of deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, signalling caution for investors amid challenging market conditions.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
02-Jun-2026 | Source : BSESubmission of newspaper clippings w.r.t Publication of Audited Financial Results for the 4th quarter and year ended 31 March 2026
Submission Of Audited Financial Results For The Quarter And Year Ended 31/03/2026
30-May-2026 | Source : BSESubmission of Audited Financial Results for the quarter and year ended 31/03/2026
Announcement under Regulation 30 (LODR)-Change in Management
30-May-2026 | Source : BSERe-appointment of Cost Auditor for FY 2026-27
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






